Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
Corcept Therapeutics(CORT) stock is priced at $45.86, giving the company a market capitalization of 4.82B. It carries a P/E multiple of 52.81.
During the trading session on 2026-01-28, Corcept Therapeutics(CORT) shares reached a daily high of $47.06 and a low of $45.24. At a current price of $45.86, the stock is +1.4% higher than the low and still -2.5% under the high.
Trading volume for Corcept Therapeutics(CORT) stock has reached 506.06K, versus its average volume of 2.28M.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
The stock's 52-week range extends from a low of $32.99 to a high of $117.33.
CORT News
Corcept Therapeutics (CORT) announced an update on their ongoing clinical study. Study Overview This study, officially titled “A Phase 1b/2, Open-Label, Dose-...
If you are wondering whether Corcept Therapeutics at around US$41.30 is priced attractively or not, the key question is how that share price lines up with the c...
Bearish flow noted in Corcept Therapeutics (CORT) with 4,870 puts trading, or 4x expected. Most active are Feb-26 37.5 puts and Feb-26 40 calls, with total volu...
Analyst ratings
71%
of 7 ratingsMore CORT News
Canaccord raised the firm’s price target on Corcept Therapeutics (CORT) to $100 from $99 and keeps a Buy rating on the shares. The firm noted they reported fina...
Corcept Therapeutics Incorporated (NASDAQ:CORT) stock is trading higher on Thursday, with a session volume of 3.06 million. The company’s ROSELLA Phase 3 trial...
Technology Why Former Highflier Corcept Therapeutics Just Surged Again Licensing Corcept Therapeutics (CORT) shares jumped Thursday after the company said its e...
Claim 50% Off TipRanks Premium Corcept Therapeutics ( (CORT) ) has issued an update. On January 22, 2026, Corcept Therapeutics reported that its pivotal Phase...
In the past few days, Corcept Therapeutics disclosed that the FDA issued a complete response letter for its cortisol‑targeting drug relacorilant, requiring more...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.